80_FR_27403 80 FR 27311 - Proposed Data Collection Submitted for Public Comment and Recommendations

80 FR 27311 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 92 (May 13, 2015)

Page Range27311-27313
FR Document2015-11511

The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the proposed information collection entitled Identification of Behavioral and Clinical Predictors of Early HIV Infection (Project DETECT).

Federal Register, Volume 80 Issue 92 (Wednesday, May 13, 2015)
[Federal Register Volume 80, Number 92 (Wednesday, May 13, 2015)]
[Notices]
[Pages 27311-27313]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-11511]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-15-15AEZ; Docket No. CDC-2015-0028]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the proposed 
information collection entitled Identification of Behavioral and 
Clinical Predictors of Early HIV Infection (Project DETECT).

DATES: Written comments must be received on or before July 13, 2015.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0028 by any of the following methods:
     Federal eRulemaking Portal: Regulation.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road, 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Please note:  All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: 
    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of 
Management and Budget (OMB) for each collection of information they 
conduct or sponsor. In addition, the PRA also requires Federal agencies 
to provide a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each new proposed 
collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and

[[Page 27312]]

maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Identification of Behavioral and Clinical Predictors of Early HIV 
Infection (Project DETECT)--New--National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC), National 
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), 
Division of HIV/AIDS Prevention (DHAP) requests a 3-year approval for a 
new data collection called ``Identification of Behavioral and Clinical 
Predictors of Early HIV Infection (Project DETECT).''
    CDC provides guidelines for HIV testing and diagnosis for the 
United States, as well as technical guidance for its grantees. CDC will 
use the HIV testing data collected for this project to update these 
guidance documents to reflect the latest available testing 
technologies, their performance characteristics, and considerations 
regarding their use. Specifically, CDC will describe the information on 
behavioral and clinical characteristics of persons with early infection 
to help HIV test providers (including CDC grantees) choose which HIV 
tests to use, and target tests appropriately to persons at different 
levels of risk. This information will be disseminated primarily through 
guidance documents and articles in peer-reviewed journals.
    The primary study population will be persons at high risk for or 
diagnosed with HIV infection, many of whom will be men who have sex 
with men (MSM) because the majority of new HIV infections occur each 
year among this population. The goals of the project are to: (1) 
characterize the performance of new HIV tests for detecting established 
and early HIV infection at the point of care, relative to each other 
and to currently used gold standard, non-POC tests, and (2) identify 
behavioral and clinical predictors of early HIV infection.
    Project DETECT will enroll 1,667 persons annually at the primary 
study site clinic in Seattle, and an additional 200 persons will be 
enrolled from other clinics in the greater Seattle area. The study will 
be conducted in two phases.
    Phase 1: After a clinic client consents to participate, he/she will 
be assigned a unique participant ID and will then undergo testing with 
the seven new HIV tests under study. While awaiting test results, 
participants will undergo additional specimen collections and complete 
the Phase 1 Enrollment Survey.
    Phase 2: All Phase 1 participants whose results on the seven tests 
under investigation are not in agreement with one another 
(``discordant'') will be considered to have a potential early HIV 
infection. Nucleic amplification testing that detects viral nucleic 
acids will be conducted to confirm an HIV diagnosis and rule out false 
positives. Study investigators expect that each year, 50 participants 
with discordant test results will be invited to participate in serial 
follow-up specimen collections to assess the time point at which all 
HIV test results resolve and become concordant positive (indicating 
enrollment during early infection) or concordant negative (indicating 
one or more false-positive test results in Phase 1).
    The follow-up schedule will consist of up to nine visits scheduled 
at regular intervals over a 70-day period. At each follow-up visit, 
participants will be tested with the new HIV tests and additional oral 
fluid and blood specimens will also be collected for storage and use in 
future HIV test evaluations at CDC. Participants will be followed up 
only to the point at which all their test results become concordant. At 
each time point, participants will be asked to complete the Phase 2 HIV 
Symptom and Care survey that collects information on symptoms 
associated with early HIV infection as well as access to HIV care and 
treatment since the last Phase 2 visit. When all tests become 
concordant (i.e., at the last Phase 2 visit) participants will complete 
the Phase 2 behavioral survey to identify any behavioral changes during 
follow-up. Of the 50 Phase 2 participants; it is estimated that no more 
than 26, annually, will have early HIV infection.
    All data for the proposed information collection will be collected 
via an electronic Computer Assisted Self-Interview (CASI) survey. 
Participants will complete the surveys on an encrypted computer, with 
the exception of the Phase 2 Symptom and Care survey, which will be 
administered by a research assistant and then electronically entered 
into the CASI system. Data to be collected via CASI include questions 
on socio-demographics, medical care, HIV testing, pre-exposure 
prophylaxis, antiretroviral treatment, sexually transmitted diseases 
(STD) history, symptoms of early HIV infection, substance use and 
sexual behavior.
    Data from the surveys will be merged with HIV test results and 
relevant clinical data using the unique identification (ID) number. 
Data will be stored on a secure server managed by the University of 
Washington Department of Medicine Information Technology (IT) Services.
    The participation of respondents is voluntary. There is no cost to 
the respondents other than their time. The total estimated annual 
burden hours for the proposed project are 2,111 hours.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of      Avg. burden
              Type of respondents                               Form name                    Number of     responses per   per response    Total burden
                                                                                            respondents     respondent      (in hours)         hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Persons eligible for study.....................  Phase 1 Consent........................           2,334               1           15/60             584
Enrolled participants..........................  Phase 1 Enrollment Survey A............           1,667               1           45/60           1,251
Enrolled participants..........................  Phase 1 Enrollment Survey B............             200               1               1             200
Enrolled participants..........................  Phase 2 Consent........................              50               1           15/60              13
Enrolled participants..........................  Phase 2 HIV Symptom and Care Survey....              50               9            5/60              38
Enrolled participants..........................  Phase 2 Behavioral Survey..............              50               1           30/60              25
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............           2,111
--------------------------------------------------------------------------------------------------------------------------------------------------------



[[Page 27313]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-11511 Filed 5-12-15; 8:45 am]
 BILLING CODE 4163-18-P



                                                                                 Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices                                                 27311

                                                    gsaadvantage.gov. The goal is to provide                accessible/visible) within GSA’s                      personal information provided. For
                                                    customer agencies with quality,                         customer-facing eTools (GSA                           access to the docket to read background
                                                    meaningful, complete data to better                     Advantage!, eBuy, etc.). In addition,                 documents or comments received, go to
                                                    search and compare products, thereby                    GSA may consider noncompliance                        Regulations.gov.
                                                    enhancing competition and saving                        when determining whether to exercise                    Please note: All public comment should be
                                                    taxpayer dollars. This endeavor is a                    the next contract option period. GSA                  submitted through the Federal eRulemaking
                                                    critical piece of a larger effort to                    might choose not to exercise the next                 portal (Regulations.gov) or by U.S. mail to the
                                                    modernize the FSS program as a whole,                   option period, thereby allowing the                   address listed above.
                                                    under which FAS aims to increase                        contract to expire.                                   FOR FURTHER INFORMATION CONTACT:       To
                                                    efficiency and effectiveness, facilitate                  Dated: May 7, 2015.                                 request more information on the
                                                    the purchase of total solutions,
                                                                                                            Lisa P. Grant,                                        proposed project or to obtain a copy of
                                                    maximize competition, and promote
                                                                                                            Deputy Assistant Commissioner, Office of              the information collection plan and
                                                    small business utilization across
                                                                                                            Acquisition Management, Federal Acquisition           instruments, contact the Information
                                                    Government.
                                                       The availability of MPN and UPC–A
                                                                                                            Service.                                              Collection Review Office, Centers for
                                                    data improves overall data integrity,                   [FR Doc. 2015–11534 Filed 5–12–15; 8:45 am]           Disease Control and Prevention, 1600
                                                    encouraging additional business from                    BILLING CODE 6820–89–P                                Clifton Road NE., MS–D74, Atlanta,
                                                    customers looking for the ability to                                                                          Georgia 30329; phone: 404–639–7570;
                                                    quickly and accurately compare                                                                                Email: omb@cdc.gov.
                                                    identical products. The standardization                 DEPARTMENT OF HEALTH AND                              SUPPLEMENTARY INFORMATION:
                                                    of part number data allows for greater                  HUMAN SERVICES                                           Under the Paperwork Reduction Act
                                                    transparency and improved business                                                                            of 1995 (PRA) (44 U.S.C. 3501–3520),
                                                    intelligence that will enable customers                 Centers for Disease Control and                       Federal agencies must obtain approval
                                                    to make smarter, data-driven buying                     Prevention                                            from the Office of Management and
                                                    decisions. Collectively, these benefits                                                                       Budget (OMB) for each collection of
                                                                                                            [60Day–15–15AEZ; Docket No. CDC–2015–
                                                    will yield increased customer                           0028]
                                                                                                                                                                  information they conduct or sponsor. In
                                                    confidence as GSA works to make the                                                                           addition, the PRA also requires Federal
                                                    FSS program the Government’s premier                    Proposed Data Collection Submitted                    agencies to provide a 60-day notice in
                                                    acquisition vehicle.                                    for Public Comment and                                the Federal Register concerning each
                                                       Unaltered MPN data is required for all               Recommendations                                       proposed collection of information,
                                                    products, except where the                                                                                    including each new proposed
                                                                                                            AGENCY: Centers for Disease Control and               collection, each proposed extension of
                                                    manufacturer has not assigned a part
                                                    number to identify the item. UPC–A                      Prevention (CDC), Department of Health                existing collection of information, and
                                                    data is required for all products for                   and Human Services (HHS).                             each reinstatement of previously
                                                    which this information is commercially                  ACTION: Notice with comment period.                   approved information collection before
                                                    available. The FAS performed market                                                                           submitting the collection to OMB for
                                                                                                            SUMMARY:    The Centers for Disease                   approval. To comply with this
                                                    research to determine the Federal
                                                                                                            Control and Prevention (CDC), as part of              requirement, we are publishing this
                                                    Supply Schedules and Special Item
                                                                                                            its continuing efforts to reduce public               notice of a proposed data collection as
                                                    Numbers (SINs) under which UPC–A
                                                                                                            burden and maximize the utility of                    described below.
                                                    data is commercially available—a
                                                                                                            government information, invites the                      Comments are invited on: (a) Whether
                                                    complete listing can be viewed at
                                                                                                            general public and other Federal                      the proposed collection of information
                                                    http://eoffer.gsa.gov.
                                                       MPN and UPC–A data is widely                         agencies to take this opportunity to                  is necessary for the proper performance
                                                    utilized throughout the commercial                      comment on proposed and/or                            of the functions of the agency, including
                                                    marketplace. FSS contractors are simply                 continuing information collections, as                whether the information shall have
                                                    providing the existing MPN and UPC–                     required by the Paperwork Reduction                   practical utility; (b) the accuracy of the
                                                    A data that is used to classify their                   Act of 1995. This notice invites                      agency’s estimate of the burden of the
                                                    awarded FSS products. Many FSS                          comment on the proposed information                   proposed collection of information; (c)
                                                    contractors have already provided this                  collection entitled Identification of                 ways to enhance the quality, utility, and
                                                    data in their price lists. In fact,                     Behavioral and Clinical Predictors of                 clarity of the information to be
                                                    approximately 8 million MPNs and 1.3                    Early HIV Infection (Project DETECT).                 collected; (d) ways to minimize the
                                                    million unique UPC–A codes are                          DATES: Written comments must be                       burden of the collection of information
                                                    currently listed in FSS contractor price                received on or before July 13, 2015.                  on respondents, including through the
                                                    lists published on gsaadvantage.gov.                    ADDRESSES: You may submit comments,                   use of automated collection techniques
                                                       Obtaining MPN and UPC–A data from                    identified by Docket No. CDC–2015–                    or other forms of information
                                                    existing FSS contractors will allow GSA                 0028 by any of the following methods:                 technology; and (e) estimates of capital
                                                    to acquire baseline information across                     • Federal eRulemaking Portal:                      or start-up costs and costs of operation,
                                                    the contracts already awarded under the                 Regulation.gov. Follow the instructions               maintenance, and purchase of services
                                                    FSS program. A bilateral ‘‘mass                         for submitting comments.                              to provide information. Burden means
                                                    modification’’ will be distributed by                      • Mail: Leroy A. Richardson,                       the total time, effort, or financial
                                                    GSA to all contractors with FSS                         Information Collection Review Office,                 resources expended by persons to
asabaliauskas on DSK5VPTVN1PROD with NOTICES




                                                    contracts that include products. FSS                    Centers for Disease Control and                       generate, maintain, retain, disclose or
                                                    contractors will be required to sign the                Prevention, 1600 Clifton Road, NE.,                   provide information to or for a Federal
                                                    modification and provide this data in                   MS–D74, Atlanta, Georgia 30329.                       agency. This includes the time needed
                                                    their price lists within 60 days of                        Instructions: All submissions received             to review instructions; to develop,
                                                    distribution.                                           must include the agency name and                      acquire, install and utilize technology
                                                       FSS contractors that do not provide                  Docket Number. All relevant comments                  and systems for the purpose of
                                                    this data will have noncompliant                        received will be posted without change                collecting, validating and verifying
                                                    products ‘‘grayed-out’’ (i.e., no longer                to Regulations.gov, including any                     information, processing and


                                               VerDate Sep<11>2014   17:27 May 12, 2015   Jkt 235001   PO 00000   Frm 00028   Fmt 4703   Sfmt 4703   E:\FR\FM\13MYN1.SGM   13MYN1


                                                    27312                                Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices

                                                    maintaining information, and disclosing                                because the majority of new HIV                                               storage and use in future HIV test
                                                    and providing information; to train                                    infections occur each year among this                                         evaluations at CDC. Participants will be
                                                    personnel and to be able to respond to                                 population. The goals of the project are                                      followed up only to the point at which
                                                    a collection of information, to search                                 to: (1) characterize the performance of                                       all their test results become concordant.
                                                    data sources, to complete and review                                   new HIV tests for detecting established                                       At each time point, participants will be
                                                    the collection of information; and to                                  and early HIV infection at the point of                                       asked to complete the Phase 2 HIV
                                                    transmit or otherwise disclose the                                     care, relative to each other and to                                           Symptom and Care survey that collects
                                                    information.                                                           currently used gold standard, non-POC                                         information on symptoms associated
                                                                                                                           tests, and (2) identify behavioral and                                        with early HIV infection as well as
                                                    Proposed Project
                                                                                                                           clinical predictors of early HIV                                              access to HIV care and treatment since
                                                      Identification of Behavioral and                                     infection.                                                                    the last Phase 2 visit. When all tests
                                                    Clinical Predictors of Early HIV                                          Project DETECT will enroll 1,667                                           become concordant (i.e., at the last
                                                    Infection (Project DETECT)—New—                                        persons annually at the primary study                                         Phase 2 visit) participants will complete
                                                    National Center for HIV/AIDS, Viral                                    site clinic in Seattle, and an additional                                     the Phase 2 behavioral survey to
                                                    Hepatitis, STD, and TB Prevention                                      200 persons will be enrolled from other                                       identify any behavioral changes during
                                                    (NCHHSTP), Centers for Disease Control                                 clinics in the greater Seattle area. The                                      follow-up. Of the 50 Phase 2
                                                    and Prevention (CDC).                                                  study will be conducted in two phases.                                        participants; it is estimated that no more
                                                                                                                              Phase 1: After a clinic client consents
                                                    Background and Brief Description                                                                                                                     than 26, annually, will have early HIV
                                                                                                                           to participate, he/she will be assigned a
                                                       The Centers for Disease Control and                                                                                                               infection.
                                                                                                                           unique participant ID and will then
                                                    Prevention (CDC), National Center for                                  undergo testing with the seven new HIV                                           All data for the proposed information
                                                    HIV/AIDS, Viral Hepatitis, STD, and TB                                 tests under study. While awaiting test                                        collection will be collected via an
                                                    Prevention (NCHHSTP), Division of                                      results, participants will undergo                                            electronic Computer Assisted Self-
                                                    HIV/AIDS Prevention (DHAP) requests a                                  additional specimen collections and                                           Interview (CASI) survey. Participants
                                                    3-year approval for a new data                                         complete the Phase 1 Enrollment                                               will complete the surveys on an
                                                    collection called ‘‘Identification of                                  Survey.                                                                       encrypted computer, with the exception
                                                    Behavioral and Clinical Predictors of                                     Phase 2: All Phase 1 participants                                          of the Phase 2 Symptom and Care
                                                    Early HIV Infection (Project DETECT).’’                                whose results on the seven tests under                                        survey, which will be administered by
                                                       CDC provides guidelines for HIV                                     investigation are not in agreement with                                       a research assistant and then
                                                    testing and diagnosis for the United                                   one another (‘‘discordant’’) will be                                          electronically entered into the CASI
                                                    States, as well as technical guidance for                              considered to have a potential early HIV                                      system. Data to be collected via CASI
                                                    its grantees. CDC will use the HIV                                     infection. Nucleic amplification testing                                      include questions on socio-
                                                    testing data collected for this project to                             that detects viral nucleic acids will be                                      demographics, medical care, HIV
                                                    update these guidance documents to                                     conducted to confirm an HIV diagnosis                                         testing, pre-exposure prophylaxis,
                                                    reflect the latest available testing                                   and rule out false positives. Study                                           antiretroviral treatment, sexually
                                                    technologies, their performance                                        investigators expect that each year, 50                                       transmitted diseases (STD) history,
                                                    characteristics, and considerations                                    participants with discordant test results                                     symptoms of early HIV infection,
                                                    regarding their use. Specifically, CDC                                 will be invited to participate in serial                                      substance use and sexual behavior.
                                                    will describe the information on                                       follow-up specimen collections to assess
                                                    behavioral and clinical characteristics of                                                                                                              Data from the surveys will be merged
                                                                                                                           the time point at which all HIV test
                                                    persons with early infection to help HIV                                                                                                             with HIV test results and relevant
                                                                                                                           results resolve and become concordant
                                                    test providers (including CDC grantees)                                positive (indicating enrollment during                                        clinical data using the unique
                                                    choose which HIV tests to use, and                                     early infection) or concordant negative                                       identification (ID) number. Data will be
                                                    target tests appropriately to persons at                               (indicating one or more false-positive                                        stored on a secure server managed by
                                                    different levels of risk. This information                             test results in Phase 1).                                                     the University of Washington
                                                    will be disseminated primarily through                                    The follow-up schedule will consist                                        Department of Medicine Information
                                                    guidance documents and articles in                                     of up to nine visits scheduled at regular                                     Technology (IT) Services.
                                                    peer-reviewed journals.                                                intervals over a 70-day period. At each                                          The participation of respondents is
                                                       The primary study population will be                                follow-up visit, participants will be                                         voluntary. There is no cost to the
                                                    persons at high risk for or diagnosed                                  tested with the new HIV tests and                                             respondents other than their time. The
                                                    with HIV infection, many of whom will                                  additional oral fluid and blood                                               total estimated annual burden hours for
                                                    be men who have sex with men (MSM)                                     specimens will also be collected for                                          the proposed project are 2,111 hours.

                                                                                                                          ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                       Number of                 Avg. burden
                                                                                                                                                                            Number of                                                                      Total burden
                                                               Type of respondents                                              Form name                                                            responses per               per response
                                                                                                                                                                           respondents                                                                        hours
                                                                                                                                                                                                       respondent                 (in hours)

                                                    Persons    eligible for study ..................         Phase 1 Consent .............................                              2,334                             1                   15/60                 584
                                                    Enrolled   participants ..........................       Phase 1 Enrollment Survey A .........                                      1,667                             1                   45/60               1,251
                                                    Enrolled   participants ..........................       Phase 1 Enrollment Survey B .........                                        200                             1                       1                 200
asabaliauskas on DSK5VPTVN1PROD with NOTICES




                                                    Enrolled   participants ..........................       Phase 2 Consent .............................                                 50                             1                   15/60                  13
                                                    Enrolled   participants ..........................       Phase 2 HIV Symptom and Care                                                  50                             9                    5/60                  38
                                                                                                               Survey.
                                                    Enrolled participants ..........................         Phase 2 Behavioral Survey .............                                          50                          1                   30/60                  25

                                                         Total ...........................................   ..........................................................   ........................   ........................   ........................          2,111




                                               VerDate Sep<11>2014       17:27 May 12, 2015        Jkt 235001      PO 00000        Frm 00029        Fmt 4703        Sfmt 4703      E:\FR\FM\13MYN1.SGM                13MYN1


                                                                                     Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices                                                           27313

                                                    Leroy A. Richardson,                                          instruments, call (404) 639–7570 or                              for prevention, including:
                                                    Chief, Information Collection Review Office,                  send an email to omb@cdc.gov. Written                            cardiovascular disease, fragility
                                                    Office of Scientific Integrity, Office of the                 comments and/or suggestions regarding                            fractures, renal and hepatic disease, and
                                                    Associate Director for Science, Office of the                 the items contained in this notice                               cancers. The HOPS remains an
                                                    Director, Centers for Disease Control and                     should be directed to the Attention:                             important source for multi-year trend
                                                    Prevention.
                                                                                                                  CDC Desk Officer, Office of Management                           data concerning conditions and
                                                    [FR Doc. 2015–11511 Filed 5–12–15; 8:45 am]
                                                                                                                  and Budget, Washington, DC 20503 or                              behaviors for which data are not readily
                                                    BILLING CODE 4163–18–P                                        by fax to (202) 395–5806. Written                                available elsewhere, including: rates of
                                                                                                                  comments should be received within 30                            opportunistic illnesses, rates of
                                                                                                                  days of this notice.                                             comorbid conditions (e.g., hypertension,
                                                    DEPARTMENT OF HEALTH AND
                                                                                                                                                                                   obesity, diabetes) and antiretroviral drug
                                                    HUMAN SERVICES                                                Proposed Project
                                                                                                                                                                                   resistance.
                                                    Centers for Disease Control and                                 HIV Outpatient Study (HOPS)—                                      Data will be collected through
                                                    Prevention                                                    New—National Center for HIV/AIDS,                                medical record abstraction by trained
                                                                                                                  Viral Hepatitis, STD, and TB Prevention                          abstractors and by telephone or internet-
                                                    [30Day–15–15JX]                                               (NCHHSTP), Centers for Disease Control                           based, computer-assisted interviews at
                                                                                                                  and Prevention (CDC).                                            nine funded study sites in six U.S.
                                                    Agency Forms Undergoing Paperwork
                                                    Reduction Act Review                                          Background and Brief Description                                 cities.
                                                                                                                                                                                      Collection of data abstracted from
                                                       The Centers for Disease Control and                           The Centers for Disease Control and
                                                                                                                                                                                   patient medical records provides data in
                                                    Prevention (CDC) has submitted the                            Prevention requests a three-year
                                                                                                                                                                                   five general categories: Demographics
                                                    following information collection request                      approval for the HIV Outpatient Study
                                                                                                                                                                                   and risk behaviors for HIV infection;
                                                    to the Office of Management and Budget                        data collection activity. The HIV
                                                                                                                                                                                   symptoms; diagnosed conditions
                                                    (OMB) for review and approval in                              Outpatient Study (HOPS) is a
                                                                                                                                                                                   (definitive and presumptive);
                                                    accordance with the Paperwork                                 prospective longitudinal cohort of HIV-
                                                                                                                                                                                   medications prescribed (including dose,
                                                    Reduction Act of 1995. The notice for                         infected outpatients at nine well-
                                                                                                                                                                                   duration, and reasons for stopping); all
                                                    the proposed information collection is                        established private HIV care practices
                                                                                                                                                                                   laboratory values, including CD4+ T-
                                                    published to obtain comments from the                         and university-based U.S. clinics.
                                                                                                                                                                                   lymphocyte (CD4+) cell counts, plasma
                                                    public and affected agencies.                                 Clinical data are abstracted on ongoing
                                                                                                                                                                                   HIV–RNA determinations, and
                                                       Written comments and suggestions                           basis from the medical records of adult
                                                                                                                                                                                   genotype, phenotype, and trophile
                                                    from the public and affected agencies                         HIV-infected HOPS study participants,
                                                                                                                                                                                   results. Data on visit frequency, AIDS,
                                                    concerning the proposed collection of                         who also complete an optional seven
                                                                                                                                                                                   and death are acquired from the clinic
                                                    information are encouraged. Your                              minute telephone/web-based behavioral
                                                                                                                                                                                   chart.
                                                    comments should address any of the                            assessment as part of their annual clinic
                                                                                                                  visit.                                                              Data collected using a brief Telephone
                                                    following: (a) Evaluate whether the
                                                                                                                     Before enrolling in this study, all                           Audio-Computer Assisted Self-
                                                    proposed collection of information is
                                                                                                                  potential study participants will                                Interview (T–ACASI) survey or an
                                                    necessary for the proper performance of
                                                                                                                  undergo an informed consent process                              identical web-based Audio-Computer
                                                    the functions of the agency, including
                                                                                                                  (including signing of a written informed                         Assisted Self-Interview (ACASI)
                                                    whether the information will have
                                                                                                                  consent) which is estimated to take 15                           include: Age, sex at birth, use of alcohol
                                                    practical utility; (b) Evaluate the
                                                                                                                  minutes.                                                         and drugs, cigarette smoking, adherence
                                                    accuracy of the agencies estimate of the
                                                                                                                     The core areas of HOPS research                               to antiretroviral medications, types of
                                                    burden of the proposed collection of
                                                                                                                  extending through the present HIV                                sexual intercourse, condom use, and
                                                    information, including the validity of
                                                                                                                  treatment era include (i) monitoring                             disclosure of HIV status to partners.
                                                    the methodology and assumptions used;
                                                    (c) Enhance the quality, utility, and                         death rates and causes of death (ii)                                We estimate consenting 450 new
                                                    clarity of the information to be                              characterizing the optimal patient                               participants per year across all HOPS
                                                    collected; (d) Minimize the burden of                         management strategies to reduce HIV-                             study sites (50 participants at each of
                                                    the collection of information on those                        related morbidity and mortality (e.g.,                           the 9 sites). The consent process takes
                                                    who are to respond, including through                         effectiveness of antiretroviral therapies                        approximately 15 minutes to complete.
                                                    the use of appropriate automated,                             and other clinical interventions (iii)                              Medical record abstractions will be
                                                    electronic, mechanical, or other                              monitoring of sexual and drug use                                completed on all eligible participants.
                                                    technological collection techniques or                        behaviors to inform Prevention with                              All eligible participants will be offered
                                                    other forms of information technology,                        Positives, and (iv) investigating                                the opportunity to participate in an
                                                    e.g., permitting electronic submission of                     disparities in the HIV care continuum                            optional short survey that will take
                                                    responses; and (e) Assess information                         by various demographic factors. In                               approximately seven minutes.
                                                    collection costs.                                             recent years, the HOPS has been                                     Participation of respondents is
                                                       To request additional information on                       instrumental in bringing attention to                            voluntary. There is no cost to the
                                                    the proposed project or to obtain a copy                      emerging issues in chronic HIV                                   respondents other than their time. The
                                                    of the information collection plan and                        infection with actionable opportunities                          estimated annual burden hours are 405.
asabaliauskas on DSK5VPTVN1PROD with NOTICES




                                                                                                                 ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                   Number of     Avg. burden
                                                                                                                                                                                   Number of
                                                                   Type of respondents                                                  Form name                                                responses per   per response
                                                                                                                                                                                  respondents      respondent      (in hrs.)

                                                    HOPS study Patients ......................................   Behavioral survey ..........................................            2,500               1           7/60
                                                    HOPS Study Patients ......................................   Consent form .................................................            450               1          15/60




                                               VerDate Sep<11>2014     17:27 May 12, 2015     Jkt 235001   PO 00000      Frm 00030     Fmt 4703      Sfmt 4703     E:\FR\FM\13MYN1.SGM    13MYN1



Document Created: 2015-12-16 07:46:58
Document Modified: 2015-12-16 07:46:58
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with comment period.
DatesWritten comments must be received on or before July 13, 2015.
ContactTo request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS- D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]
FR Citation80 FR 27311 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR